Q3 2024 Addex Therapeutics Ltd Earnings Call Transcript
Hello, everyone. I would like to thank you all for attending our third quarter 2024 financial results conference call. I'm here with Mikhail Kalinichev, our Head of Translational Science who will provide an update on our R&D programs. I draw your attention to the press release and the financial statements issued earlier today, which are available on our website.
I also draw your attention to our disclaimers. We will be making certain forward-looking statements that are based on the knowledge we have today. I will start this conference call by giving a quick overview of our recent activities and achievements before reviewing our pipeline. I will then hand over to Misha who will review in more detail our GABAB PAM preclinical program. I will then review our third-quarter 2024 financial results. Following that, we will open the call for questions.
So we have made excellent progress in our GABAB positive allosteric modulator program with the completion of the R&D
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |